Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 3526903, 8 pages
https://doi.org/10.1155/2017/3526903
Research Article

Amelioration of Ethanol-Induced Hepatitis by Magnesium Isoglycyrrhizinate through Inhibition of Neutrophil Cell Infiltration and Oxidative Damage

1Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China
2Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing 100069, China

Correspondence should be addressed to Yan Wang; nc.ude.umjb@gnawnaygnaw

Received 5 July 2017; Accepted 13 August 2017; Published 29 August 2017

Academic Editor: Ju Qiu

Copyright © 2017 Yan Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Rehm, A. V. Samokhvalov, and K. D. Shield, “Global burden of alcoholic liver diseases,” Journal of Hepatology, vol. 59, no. 1, pp. 160–168, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. L. E. Nagy, W. X. Ding, G. Cresci, P. Saikia, and V. H. Shah, “Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes,” Gastroenterology, vol. 150, no. 8, pp. 1756–1768, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Gao and R. Bataller, “Alcoholic liver disease: pathogenesis and new therapeutic targets,” Gastroenterology, vol. 141, no. 5, pp. 1572–1585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Dominguez, R. Miquel, J. Colmenero et al., “Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis,” Gastroenterology, vol. 136, no. 5, pp. 1639–1650, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Jaeschke, “Neutrophil-mediated tissue injury in alcoholic hepatitis,” Alcohol, vol. 27, no. 1, pp. 23–27, 2002. View at Google Scholar
  6. Y. Yan, Y. Mo, and D. Zhang, “Magnesium isoglycyrrhizinate prevention of chemotherapy-induced liver damage during initial treatment of patients with gastrointestinal tumors,” Zhonghua Gan Zang Bing Za Zhi, vol. 23, no. 3, pp. 204–208, 2015. View at Google Scholar
  7. Z. H. Yan, Y. M. Wang, B. Tang et al., “Meta-analysis of magnesium isoglycyrrhizinate combined with nucleoside analogues in patients with chronic hepatitis B,” Zhonghua Gan Zang Bing Za Zhi, vol. 22, no. 2, pp. 108–112, 2014. View at Google Scholar
  8. Y. M. Mao, M. D. Zeng, Y. Chen et al., “Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study,” Zhonghua Gan Zang Bing Za Zhi, vol. 17, no. 11, pp. 847–851, 2009. View at Google Scholar
  9. G. H. Tang, H. Y. Yang, J. C. Zhang et al., “Magnesium isoglycyrrhizinate inhibits inflammatory response through STAT3 pathway to protect remnant liver function,” World Journal of Gastroenterology, vol. 21, no. 43, pp. 12370–12380, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Yang, J. Wang, R. Liu et al., “Amelioration of concanavalin A-induced autoimmune hepatitis by magnesium isoglycyrrhizinate through inhibition of CD4+CD25CD69+ subset proliferation,” Drug Design, Development and Therapy, vol. 10, pp. 443–453, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Xie, X. Li, J. Wu et al., “Anti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase A2/arachidonic acid pathway,” Inflammation, vol. 38, no. 4, pp. 1639–1648, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Huang, J. Qin, and S. Lu, “Magnesium isoglycyrrhizinate protects hepatic L02 cells from ischemia/reperfusion induced injury,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 8, pp. 4755–4764, 2014. View at Google Scholar
  13. W. Jiang, J. Liu, P. Li et al., “Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury,” Oncotarget, vol. 8, no. 20, pp. 33252–33264, 2017. View at Publisher · View at Google Scholar
  14. B. Qu, R. Xing, H. Wang et al., “Multiple effects of magnesium isoglycyrrhizinate on the disposition of docetaxel in docetaxel-induced liver injury,” Xenobiotica, vol. 47, no. 4, pp. 290–296, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Xu, J. Wang, F. Chen et al., “Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms,” International Journal of Molecular Medicine, vol. 38, no. 1, pp. 275–282, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Lu, W. Xu, J. Shao, F. Zhang, A. Chen, and S. Zheng, “Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis,” IUBMB Life 7, 2017. View at Google Scholar
  17. A. Bertola, S. Mathews, S. H. Ki, H. Wang, and B. Gao, “Mouse model of chronic and binge ethanol feeding (the NIAAA model),” Nature Protocols, vol. 8, no. 3, pp. 627–637, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Li, Y. He, Z. Zhou et al., “MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils,” Gut, vol. 66, no. 4, pp. 705–715, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. S. H. Ki, O. Park, M. Zheng et al., “Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3,” Hepatology, vol. 52, no. 4, pp. 1291–1300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Bertola, O. Park, and B. Gao, “Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin,” Hepatology, vol. 58, no. 5, pp. 1814–1823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. V. Varga, C. Matyas, K. Erdelyi et al., “Beta-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice,” British Journal of Pharmacology, 2017. View at Publisher · View at Google Scholar
  22. S. Das, J. S. Maras, M. S. Hussain et al., “Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis,” Hepatology, vol. 65, no. 2, pp. 631–646, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Gao and M. Xu, “Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?” Gut, vol. 63, no. 11, pp. 1683-1684, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. W. H. Chen, L. G. Lu, M. D. Zeng et al., “Effect of magnesium isoglycyrrhizinate on the proliferation and oxidative stress of rat hepatic stellate cells in vitro,” Zhonghua Gan Zang Bing Za Zhi, vol. 14, no. 6, pp. 426–430, 2006. View at Google Scholar
  25. Y. Cheng, J. Zhang, J. Shang, and L. Zhang, “Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro,” Pharmacology, vol. 84, no. 3, pp. 183–190, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Jin, J. M. Xu, X. C. Liu, and Q. Mei, “Effect of magnesium isoglycyrrhizinate on concanavalin A (Con A)-induced immunological liver injury in mice,” Zhonghua Gan Zang Bing Za Zhi, vol. 17, no. 5, pp. 389-390, 2009. View at Publisher · View at Google Scholar
  27. B. Vincenzi, G. Armento, M. Spalato Ceruso et al., “Drug-induced hepatotoxicity in cancer patients - implication for treatment,” Expert Opinion on Drug Safety, vol. 15, no. 9, pp. 1219–1238, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Zhao, Z. Tang, W. Zhang, J. Liu, and B. Li, “Magnesium isoglycyrrhizinate protects against renalischemiareperfusion injury in a rat model via antiinflammation, antioxidation and antiapoptosis,” Molecular Medicine Reports, vol. 16, no. 3, pp. 3627–3633, 2017. View at Publisher · View at Google Scholar